603456 九洲藥業
按盤價 
20.120 -1.340 (-6.244%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.647 | 7.131 | 15.020 | 18.659 | 16.550 |
| 總資產報酬率 ROA (%) | 6.845 | 5.515 | 11.012 | 12.320 | 10.528 |
| 投入資產回報率 ROIC (%) | 7.978 | 6.439 | 13.196 | 15.313 | 12.717 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.552 | 33.783 | 37.656 | 34.660 | 33.327 |
| 營業利潤率 (%) | 21.929 | 14.188 | 21.287 | 20.347 | 18.548 |
| 息稅前利潤/營業總收入 (%) | 21.439 | 12.649 | 20.006 | 18.689 | 19.244 |
| 淨利潤/營業總收入 (%) | 17.995 | 11.764 | 18.673 | 16.914 | 15.607 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.083 | 127.672 | 105.670 | 105.420 | 98.121 |
| 價值變動淨收益/利潤總額(%) | -0.323 | -1.113 | -1.640 | -3.003 | 8.013 |
| 營業外收支淨額/利潤總額(%) | -0.280 | -0.217 | 0.413 | -0.371 | -1.194 | 償債能力分析 |
| 流動比率 (X) | 3.393 | 2.967 | 3.812 | 1.804 | 1.809 |
| 速動比率 (X) | 2.420 | 2.025 | 2.629 | 0.891 | 1.003 |
| 資產負債率 (%) | 17.675 | 22.626 | 21.369 | 32.119 | 34.988 |
| 帶息債務/全部投入資本 (%) | 2.996 | 6.638 | 6.929 | 11.708 | 17.404 |
| 股東權益/帶息債務 (%) | 3,141.782 | 1,362.182 | 1,301.104 | 720.957 | 456.889 |
| 股東權益/負債合計 (%) | 462.130 | 339.070 | 364.874 | 208.389 | 185.813 |
| 利息保障倍數 (X) | -50.038 | -8.385 | -14.610 | -11.810 | 21.023 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.307 | 75.262 | 53.230 | 47.541 | 62.786 |
| 存貨周轉天數 (天) | 182.404 | 204.811 | 208.092 | 187.365 | 189.485 |
| 備註： | 即時報價更新時間為 19/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
